Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Sosnowiec – page 76

1 193 clinical trials in Sosnowiec, Poland across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Sosnowiec at a glance
1 193
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

1 193 trials in Sosnowiec

Open in trial search

Neoplasm

Not recruiting

Study of RVU120 for Patients with Advanced Solid Tumors After Standard Treatments Have Failed

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Romaciclib
  • Sponsor:Ryvu Therapeutics S.A.

Study on Long-Term Safety and Effectiveness of Ofatumumab for Patients with Relapsing Multiple Sclerosis

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Ofatumumab
  • Sponsor:Novartis Pharma AG

Myasthenia gravis

Not recruiting

Study on the Safety and Tolerability of DNTH103 for Adults with Generalized Myasthenia Gravis

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:DNTH103
  • Sponsor:Dianthus Therapeutics Inc.

Dermatitis atopic

Not recruiting

Study on the Effectiveness of Ruxolitinib Cream for Adults with Moderate Atopic Dermatitis

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Ruxolitinib
  • Sponsor:Incyte Corp.

Study on Adding Nivolumab to Cisplatin and Radiotherapy for High-Risk Patients with Head and Neck Squamous Cell Carcinoma

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Cisplatin
  • Sponsor:Groupe Oncologie Radiotherapie Tete Cou

Asthma+1

Not recruiting

Study on the Effects of ARO-MUC5AC Inhalation Solution for Patients with Asthma and COPD

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:ADS-013
  • Sponsor:Arrowhead Pharmaceuticals Inc.

Study Comparing the Effectiveness and Safety of Macitentan 75 mg and 10 mg for Patients with Pulmonary Arterial Hypertension

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Macitentan
  • Sponsor:Actelion Pharmaceuticals Ltd.

Migraine

Not recruiting

Study on Rimegepant for Treating Migraine in Adults Who Cannot Use Triptans

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Rimegepant
  • Sponsor:Pfizer Inc.

Migraine

Not recruiting

Study on Rimegepant for Preventing Migraines in Adults with Poor Response to Oral Preventive Medications

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Rimegepant
  • Sponsor:Pfizer Inc.

Study of Lu AG22515 for Adults with Moderate-to-Severe Thyroid Eye Disease

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Velaprumig
  • Sponsor:H. Lundbeck A/S

Pemphigoid

Not recruiting

Study of dupilumab effectiveness compared to placebo in adults with bullous pemphigoid

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Dupilumab
  • Sponsor:Regeneron Pharmaceuticals Inc.

Acute myeloid leukaemia+10

Not recruiting

Long-Term Access to Ibrutinib for Patients with Lymphoma, Leukemia, and Other Conditions

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Ibrutinib
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Other cities in Poland

The busiest research cities in the country

All 236 cities in Poland

Clinical research in Sosnowiec

What the registry says about research in the country

01 Respiratory Diseases

Innovative clinical trials focusing on chronic obstructive pulmonary disease (COPD) and asthma management, testing new inhaler formulations and investigating treatments for respiratory conditions including respiratory syncytial virus (RSV).

  • COPD Treatment Optimization
  • Asthma Management
  • Respiratory Infections

Studies include evaluation of triple therapy combinations and novel propellant technologies for improved drug delivery.

02 Dermatological Conditions

Research examining treatments for various skin conditions, including atopic dermatitis, psoriasis, and hidradenitis suppurativa, with particular focus on innovative biological therapies.

  • Inflammatory Skin Diseases
  • Pediatric Dermatology
  • Chronic Skin Conditions

Clinical investigations include both adult and pediatric populations, testing new targeted therapies.

03 Gastrointestinal Disorders

Studies evaluating treatments for inflammatory bowel conditions, particularly Crohn's disease and ulcerative colitis, testing novel therapeutic approaches for disease management.

  • Inflammatory Bowel Disease
  • Long-term Disease Management
  • Novel Therapeutic Approaches

Focus on both induction and maintenance therapy for moderate to severe disease states.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.